The manufacturer of a medical instrument for endoscopic procedures, Olympus Corp, lacked US FDA clearance to sell the current version when it caused an outbreak of infections, including two deaths, from an antibiotic-resistant strain of bacteria, "superbug" Carbapenem-resistant enterobacteriaceae, or CRE, at Ronald Reagan UCLA Medical Center between October 2014 and January 2015 (see February 19). (AP)